Species |
Human |
Lewis rat |
CD1 mice, AQP4 KO mice, nude mice |
Lewis rat |
Lewis rat |
Lewis rat |
Lewis rat |
Lewis rat |
Method |
Human disease |
Intracerebral injection of cytokine and NMO‐IgG |
Repeated intracerebral injection of NMO‐IgG and human complement into brain parenchyma and ventricles |
Passive transfer of MBP T cell line (passive EAE) + NMO‐IgG |
Recombinant human AQP4 Ab into the retrobulbar venous plexus of MBP EAE |
Intraperitoneal injecting AQP4‐specific T cells/intraperitoneal NMO‐IgG |
Immunization with MBP inducing EAE/intraperitoneal NMO‐IgG |
CFA treatment; intraperitoneal injection of NMO‐IgG |
CNS trauma |
No |
Yes |
Yes |
No |
No |
No |
No |
No |
Demyelination |
Yes |
No |
Yes |
No |
No (only perivascular myelin vacuolization) |
No |
Unknown |
Unknown |
T lymphocyte inflammation |
Yes |
Yes |
Yes/(No in nude mice) |
Yes |
Yes |
Yes |
Yes |
Limited |
Macrophage/microglial reaction |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Granulocyte infiltration |
Neutrophil and eosinophil |
Neutrophil |
Neutrophil |
Neutrophil |
Unknown |
Neutrophil |
Neutrophil and eosinophil |
Granulocytes |
AQP4 loss |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
GFAP loss |
Yes (variable) |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Yes |
Other astrocyte pathology |
Both astrocytic lytic and sublytic changes |
Loss of astrocytes |
Loss of astrocytes |
Swollen astrocyte, astrocytic destruction |
Loss of astrocytic bodies and processes |
Unknown |
Balloon‐like dying astrocyte |
Swelling of astrocytes |
Immune complex deposition |
Perivascular complement and IgG deposition |
Perivascular and astrocytic complement deposition |
Vasculocentric complement deposition |
Perivascular IgG and complement deposition |
Perivascular IgG and complement deposition |
Perivascular IgG and complement deposition |
Perivascular deposition of Ig and complement |
Perivascular deposition of Ig and complement |
Axonal pathology |
Yes (severe) |
Unknown |
Yes |
No |
Unknown |
Unknown |
Unknown |
Unknown |